Medical 21 Secures Up To $20 Million Commitment For Its Pioneering Cardiac Bypass Technology
09/20/22, 12:05 PM
Location
minneapolisMoney raised
$20 million
Industry
biotechnology
Medical 21, a medtech company aiming to transform heart bypass surgery with a revolutionary artificial graft, says it has successfully closed a $20 million commitment pursuant to Regulation D, Rule 506(c) under the Securities Act of 1933, as amended, to implement its business plan.
Company Info
Location
15070 23rd avenue north
minneapolis, minnesota, united states
Additional Info
Medical 21, Inc. is a developmental stage medical device company founded by Dr. Manny Villafaña and located in Minneapolis, MN. We are developing and intend to commercialize and market an artificial graft to bypass blockages in the heart.